Cancer Research 2010 AACR Elections  2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, H.
Right arrow Articles by Jorgensen, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, H.
Right arrow Articles by Jorgensen, T. J.
[Cancer Research 60, 679-684, February 1, 2000]
© 2000 American Association for Cancer Research


Experimental Therapeutics

p21WAF1/CIP1 Antisense Therapy Radiosensitizes Human Colon Cancer by Converting Growth Arrest to Apoptosis1

Hui Tian, Ellen K. Wittmack and Timothy J. Jorgensen2

Department of Radiation Medicine, Lombardi Cancer Center, Georgetown University Medical Center, Washington, D.C. 20007-2197

Substantial evidence suggests that loss of cellular p21WAF1/CIP1 results in increased apoptotic killing by ionizing radiation. We hypothesized that a p21 antisense (AS) oligodeoxynucleotide (ODN) could be used to sensitize cancer cells to radiotherapy. In vitro treatment of colon cancer cells (HCT116/p21+/+) with p21 AS ODN (200 nM) led to inhibition of radiation-induced p21 expression (>95% inhibition, 0–30 Gy), resulting in a loss of G1 arrest and an enhancement of apoptosis to comparable levels and with similar kinetics to HCT116/p21-/- cells (~60% apoptotic cells at 96 h after 10 Gy). In vivo, p21 AS ODN in combination with radiation (i.p. ODN for 6 days at 20 mg/kg/day and 15 Gy) increased apoptosis in s.c. p21+/+ tumors in nude mice to levels similar to those of p21-/- tumors (2-fold at 24 h postirradiation) and improved radiocurability of p21+/+ tumors to levels comparable to those of p21-/- tumors (p21+/+, two of eight cures versus p21-/-, two of nine cures). Our findings suggest that p21 AS treatment may be a rational approach to improve conventional radiotherapy outcomes.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Stoyanova, N. Roy, D. Kopanja, S. Bagchi, and P. Raychaudhuri
DDB2 decides cell fate following DNA damage
PNAS, June 30, 2009; 106(26): 10690 - 10695.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Barkic, S. Crnomarkovic, K. Grabusic, I. Bogetic, L. Panic, S. Tamarut, M. Cokaric, I. Jeric, S. Vidak, and S. Volarevic
The p53 Tumor Suppressor Causes Congenital Malformations in Rpl24-Deficient Mice and Promotes Their Survival
Mol. Cell. Biol., May 15, 2009; 29(10): 2489 - 2504.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Fragkos, J. Jurvansuu, and P. Beard
H2AX Is Required for Cell Cycle Arrest via the p53/p21 Pathway
Mol. Cell. Biol., May 15, 2009; 29(10): 2828 - 2840.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
B. S. Min, Y. J. Choi, H. R. Pyo, H. Kim, J. Seong, H. C. Chung, S. Y. Rha, and N. K. Kim
Cyclooxygenase-2 Expression in Pretreatment Biopsy as a Predictor of Tumor Responses After Preoperative Chemoradiation in Rectal Cancer
Arch Surg, November 1, 2008; 143(11): 1091 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
D Bonofiglio, H Qi, S Gabriele, S Catalano, S Aquila, M Belmonte, and S Ando
Peroxisome proliferator-activated receptor {gamma} inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner
Endocr. Relat. Cancer, June 1, 2008; 15(2): 545 - 557.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Fujiwara, S. Daido, A. Yamamoto, R. Kobayashi, T. Yokoyama, H. Aoki, E. Iwado, N. Shinojima, Y. Kondo, and S. Kondo
Pivotal Role of the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 in Apoptosis and Autophagy
J. Biol. Chem., January 4, 2008; 283(1): 388 - 397.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Zhan, J. B. Easton, S. Huang, A. Mishra, L. Xiao, E. R. Lacy, R. W. Kriwacki, and P. J. Houghton
Negative Regulation of ASK1 by p21Cip1 Involves a Small Domain That Includes Serine 98 That Is Phosphorylated by ASK1 In Vivo
Mol. Cell. Biol., May 1, 2007; 27(9): 3530 - 3541.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Sohn, F. Essmann, K. Schulze-Osthoff, and R. U. Janicke
p21 Blocks Irradiation-Induced Apoptosis Downstream of Mitochondria by Inhibition of Cyclin-Dependent Kinase-Mediated Caspase-9 Activation
Cancer Res., December 1, 2006; 66(23): 11254 - 11262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Zhou, Y. Fujigaki, A. Kato, T. Miyaji, H. Yasuda, T. Tsuji, T. Yamamoto, K. Yonemura, and A. Hishida
Inhibition of p21 modifies the response of cortical proximal tubules to cisplatin in rats
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F225 - F235.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. K. Radhakrishnan and A. L. Gartel
A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity.
Cancer Res., March 15, 2006; 66(6): 3264 - 3270.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Brown and S. Benchimol
The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation: CELL CYCLE ARREST OR APOPTOSIS
J. Biol. Chem., February 17, 2006; 281(7): 3832 - 3840.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Cook, Z. Wang, S. Alber, K. Liu, S. C. Watkins, Y. Vodovotz, T. R. Billiar, and D. Blumberg
Nitric Oxide and Ionizing Radiation Synergistically Promote Apoptosis and Growth Inhibition of Cancer by Activating p53
Cancer Res., November 1, 2004; 64(21): 8015 - 8021.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Han, N. Sidell, P. B. Fisher, and J. Roman
Up-regulation of p21 Gene Expression by Peroxisome Proliferator-Activated Receptor {gamma} in Human Lung Carcinoma Cells
Clin. Cancer Res., March 15, 2004; 10(6): 1911 - 1919.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Kim, S. Kook, D. J. Kim, C. Teodorof, and W. K. Song
The 31-kDa Caspase-generated Cleavage Product of p130cas Functions as a Transcriptional Repressor of E2A in Apoptotic Cells
J. Biol. Chem., February 27, 2004; 279(9): 8333 - 8342.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Wang, T. Cook, S. Alber, K. Liu, I. Kovesdi, S. K. Watkins, Y. Vodovotz, T. R. Billiar, and D. Blumberg
Adenoviral Gene Transfer of the Human Inducible Nitric Oxide Synthase Gene Enhances the Radiation Response of Human Colorectal Cancer Associated with Alterations in Tumor Vascularity
Cancer Res., February 15, 2004; 64(4): 1386 - 1395.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. Rau, I. Sturm, H. Lage, S. Berger, U. Schneider, S. Hauptmann, P. Wust, H. Riess, P. M. Schlag, B. Dorken, et al.
Dynamic Expression Profile of p21WAF1/CIP1 and Ki-67 Predicts Survival in Rectal Carcinoma Treated With Preoperative Radiochemotherapy
J. Clin. Oncol., September 15, 2003; 21(18): 3391 - 3401.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. B.Y. Ma, R. G. Bristow, J. Kim, and L. L. Siu
Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents
J. Clin. Oncol., July 15, 2003; 21(14): 2760 - 2776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Javelaud and F. Besancon
Inactivation of p21WAF1Sensitizes Cells to Apoptosis via an Increase of Both p14ARF and p53 Levels and an Alteration of the Bax/Bcl-2 Ratio
J. Biol. Chem., September 27, 2002; 277(40): 37949 - 37954.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. L. Gartel and A. L. Tyner
The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis
Mol. Cancer Ther., June 1, 2002; 1(8): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, D. Dowbenko, and L. A. Lasky
AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell Survival
J. Biol. Chem., March 22, 2002; 277(13): 11352 - 11361.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Chattopadhyay, M. K. Ghosh, A. Mal, and M. L. Harter
Inactivation of p21 by E1A Leads to the Induction of Apoptosis in DNA-Damaged Cells
J. Virol., October 15, 2001; 75(20): 9844 - 9856.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Huang, L. N. Liu, H. Hosoi, M. B. Dilling, T. Shikata, and P. J. Houghton
p53/p21CIP1 Cooperate in Enforcing Rapamycin-induced G1 Arrest and Determine the Cellular Response to Rapamycin
Cancer Res., April 1, 2001; 61(8): 3373 - 3381.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. R. Karpf, B. C. Moore, T. O. Ririe, and D. A. Jones
Activation of the p53 DNA Damage Response Pathway after Inhibition of DNA Methyltransferase by 5-Aza-2'-deoxycytidine
Mol. Pharmacol., April 1, 2001; 59(4): 751 - 757.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. J. Khanna, R. Brown, A. D. Whetton, K. L. Ball, and C. Dive
v-Abl Protein-tyrosine Kinase Up-regulates p21WAF-1 in Cell Cycle Arrested and Proliferating Myeloid Cells
J. Biol. Chem., March 30, 2001; 276(14): 11143 - 11150.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.